Skin Rejuvenation. Atrophic disorder of skin, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In this study, own of the patient's blood derivatives (Serum Rich Growth factors/SRGF) is used. This product is injected 3 times at intervals of 3 weeks to patients
Sponsors
Skin & Stem Cell Research Center, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 59 Years
Inclusion criteria
Inclusion criteria: Female gender Presence of aging signs of periorbital with grade 3-5 Patients aged between 30-50 years Patients desire to microneedling and blood sampling
Exclusion criteria
Exclusion criteria: Menopause patients Patients that received systemic retinoids treatments (in recent 6 months) or local retinoids treatments (in recent 2 weeks) History of hemorrhagic disorders or recent receiving anti-coagulant treatments Any factor that inhibit low invasive techniques Patients with autoimmune diseases. Women in pregnant or lactation period Doing skin procedures and racer-facing lasers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin Elasticity. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Specific Equipment.;Skin Moisture. Timepoint: Before intervention and 2 month after intervention. Method of measurement: Specific Equipment.;Skin Pigmentation distribution. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Specific Equipment.;Sebum Activity. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Specific Equipment.;Skin oil. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Specific Equipment.;Skin Wrinkle. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Farsinejad
Kerman University of Medical Sciences
Outcome results
None listed